EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide

H Ganesan, V K Gupta iD, M C Safir iD, S M Bhavnani iD, A K Talley, D Melnick iD, C M Rubino iD

Antimicrobial Agents and Chemotherapy · 15.06.2023 · 67 (6)

DOI: 10.1128/aac.01451-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 15.06.2023. Verfasst von H Ganesan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA. Hauptthemen laut MEDLINE: Prodrugs, Urinary Tract Infections, Pyelonephritis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an oral (PO) carbapenem pro-drug that is converted to the active moiety tebipenem in the enterocytes. Tebipenem has activity against multidrug-resistant Gram-negative pathogens, including extended-spectrum beta lactamase-producing Enterobacterales, and is being developed for the treatment of patients with complicated urinary tract infections (cUTI) and acute pyelonephritis (AP).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsUrinary Tract InfectionsPyelonephritisHumansAnti-Bacterial AgentsCarbapenemsMonobactamsAdministration, Oral

Stichwörter der Autor:innen

population pharmacokineticstebipenem

Substanzen

L 084tebipenemAnti-Bacterial AgentsProdrugsCarbapenemsMonobactams

Autor:innen und Institutionen

  • Institute for Clinical Pharmacodynamics, Inc., Schenectady, New York, USA.
  • Spero Therapeutics, Inc., Cambridge, Massachusetts, USA.

ORCID-Profile: V K Gupta, M C Safir, S M Bhavnani, D Melnick, C M Rubino

Zitieren

APA

Ganesan, H., Gupta, V. K., Safir, M. C., Bhavnani, S. M., Talley, A. K., Melnick, D., & Rubino, C. M. (2023). Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide. Antimicrobial Agents and Chemotherapy, 67(6). https://doi.org/10.1128/aac.01451-22

Vancouver

Ganesan H, Gupta VK, Safir MC, Bhavnani SM, Talley AK, Melnick D, et al. Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide. Antimicrobial Agents and Chemotherapy. 2023;67(6). doi:10.1128/aac.01451-22

BibTeX
@article{Ganesan2023,
  author = {Ganesan, H and Gupta, V K and Safir, M C and Bhavnani, S M and Talley, A K and Melnick, D and Rubino, C M},
  title = {Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  volume = {67},
  number = {6},
  doi = {10.1128/aac.01451-22}
}
Kostenlos starten →